Plain-English translation of NCT06166147 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Researchers are developing a new blood test that could detect pancreatic cancer early by looking for cancer signals in your blood. This study compares blood samples from people recently diagnosed with pancreatic cancer, people with non-cancerous pancreatic conditions, and healthy people to train a computer program to recognize cancer signals. If successful, this blood test could someday help catch pancreatic cancer at earlier, more treatable stages.
Pancreatic cancer is often found late because there are no simple early warning signs, which makes it hard to treat. Researchers hope this new blood test could find pancreatic cancer much earlier, when treatment may be more effective.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have one blood sample taken from your arm—the same way blood is drawn for routine medical tests. The researchers will analyze your blood to look for cancer signals using advanced genetic sequencing and computer analysis. Your participation involves a single visit, though the study team may ask you questions about your medical history to help them understand your results.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China
Sponsor
Fudan University
Collaborators
Shanghai Weihe Medical Laboratory Co., Ltd.
Enrollment target
~276 participants
Started
December 2023
Primary completion
October 2026
Age range
40 Years – 75 Years
Last updated on clinicaltrials.gov in September 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xian-Jun Yu, M.D., Ph.D.
Fudan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.